tuftsin has been researched along with Bright Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barshak, I; Bashi, T; Ben-Ami Shor, D; Blank, M; Fridkin, M; Gendelman, O; Shoenfeld, Y; Versini, M; Volkov, A | 1 |
1 other study(ies) available for tuftsin and Bright Disease
| Article | Year |
|---|---|
Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.
Topics: Animals; Autoantibodies; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Glomerular Mesangium; Glomerulonephritis; Humans; Injections, Subcutaneous; Interleukin-2 Receptor alpha Subunit; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred NZB; Phosphorylcholine; T-Lymphocytes, Regulatory; Tuftsin | 2015 |